Table 3.
Diseases | Causative Genes | Possible Function |
---|---|---|
Venous malformation | TIE2, PIK3CA, Akt | Affect cytokine expression, resulting in misguiding of smooth muscle cells to the surroundings of blood vessels and leading to abnormal venous dilation Induce both proliferation and senescence of endothelial cells, which leads to morphological abnormalities |
Glomuvenous malformation | Glomulin | Inhibit TGF-β-mediated smooth muscle cell differentiation and induce the proliferation of immature glomus cells Activate PI3K signals through interactions with c-met |
Lymphatic malformation | PIK3CA | Stimulate cytokine expression Induce the binding of PIK3CA to the cellular membrane, or increase endothelial cell proliferation, chemotaxis, and angiogenesis |
Arteriovenous malformation | RAS | Induce morphological changes in endothelial cells Induce sprouting behavior, enlargement of the vessel lumen, and abnormal connections between arteries and veins |
Klippel-Trenaunay syndrome | PIK3CA | Mosaic mutations in the early embryonic phase cause segmental hypergrowth |
Capillary malformation Sturge-Weber syndrome |
GNAQ, GNA11 | Impair the ability of endothelial cells to distinguish between laminar and disturbed flow Activate the PIK3/Akt pathway |
Infantile hemangioma |
VEGFR2
TEM8, etc. |
Increase the interaction among VEGFR2, TEM8 and integrin Subsequent inactivation of the integrin-NFATc2-VEGFR1 pathway cause VEGFR2 phosphorylation and endothelial activation |
Tufted angioma Kaposiform hemangioendothelioma |
GNA14 | ? |